The Minimal Clinically Important Difference for the “Patient Activation Measure”
These values should allow researchers and health care professionals to better interpret improvements from a patient's perspective and could be beneficial in determining whether changes in PAM-13 scores are clinically meaningful to a CKD population.
Authors
- Matthew Graham‐Brown (ORCID: https://orcid.org/0000-0002-6197-180X)
- Alice C. Smith (ORCID: https://orcid.org/0000-0002-9234-9060)
- Courtney J. Lightfoot (ORCID: https://orcid.org/0000-0002-5855-4159)
- Thomas J. Wilkinson (ORCID: https://orcid.org/0000-0002-7855-7752)
- Noemi Vadaszy (ORCID: https://orcid.org/0000-0002-3005-4865)
- E Ford (ORCID: https://orcid.org/0009-0006-4565-3066)
- Devika Nair (ORCID: https://orcid.org/0000-0001-7164-715X)
- Gurneet K. Sohansoha
Institutions
- University of Leicester (GB)
- Leicester General Hospital (GB)
- University Hospitals of Leicester NHS Trust (GB)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1016/j.ekir.2025.04.044
- Citations
- 4
- Primary Topic
- Cardiac Health and Mental Health
- Type
- article
- Field-Weighted Citation Impact
- 5.55
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care